The effectiveness of Hyaluronic acid/Chondroitin injection on knee performance after surgical fixation.
Phase 2
Recruiting
- Conditions
- Fracture of patella.Fracture of upper end of tibiaS82.1
- Registration Number
- IRCT20170608034390N13
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Adult patients in the age range of 18 to 65 years with a fracture of the tibial plateau
Sign the written consent form
Exclusion Criteria
Uncontrolled diabetes
Severe Osteoarthritis
Severe osteoporosis
Open fractures
Inability to perform internal fixation due to tissue damage
Impossibility of performing internal fixation due to past medical history
Infectious diseases in the knee joint or surrounding tissues
Patients with active rheumatological disorders
Pregnancy
Lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie HA/Chondroitin's effect on knee cartilage repair post-tibial plateau fracture surgical fixation?
How does HA/Chondroitin injection compare to corticosteroids in improving knee function after patellar fracture surgery?
Which biomarkers correlate with response to high molecular weight HA/Chondroitin in post-traumatic knee osteoarthritis patients?
What adverse events are reported in phase II trials of HA/Chondroitin for post-surgical knee recovery in S82.1 fracture patients?
Are combination therapies with PRP or stem cells more effective than HA/Chondroitin for knee performance after tibial plateau fracture fixation?